Comparison

Human Apo-A1 Protein, His Tag European Partner

Item no. AP1-H5225-50ug
Manufacturer ACROBiosystems
Amount 50 ug
Category
Type Proteins Recombinant
Format Powder
Specific against Human
Host HEK293
Conjugate/Tag Unconjugated, HIS
Purity 95%
Citations (1) Wasan KM , et al. 2008, Nature Reviews Drug Discovery 7 (1): 84-99. (2) Yui Y, et al. 1988, J. Clin. Invest. 82 (3): 803-7. (3) Eggerman, T.L. et al., 1991, J. Lipid Res. 32: 821-828. (4) Voyiaziakis, E. et al., 1998. J. Lipid Res. 39: 313-321.
ECLASS 5.1 34160400
ECLASS 6.1 34160400
ECLASS 8.0 42020190
ECLASS 9.0 42020190
ECLASS 10.0.1 32160409
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Apolipoprotein A-I,APOA1,MGC117399
Available
Manufacturers Category
Protein / Bio-Markers & CD Antigens
Description
Human Apo-A1, His Tag (AP1-H5225) is expressed from human 293 cells (HEK293). It contains AA Arg 19 - Gln 267 (Accession # NP_000030.1).
Molecule
Apo-A1
Exp Region
Arg 19 - Gln 267
Storage
-20℃
Shipping
RT
Stability
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Molecular Weight
29.8 kDa
Characteristics
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 29.8 kDa. The protein migrates as 27 kDa under reducing (R) condition (SDS-PAGE).
Endotoxin
1.0 EU per μg
Buffer
PBS, pH7.4
Background
ApoA1 is also known as apolipoprotein A-I, ApoA-I , and is the major protein component of high density lipoprotein (HDL) in plasma. It has a specific role in lipid metabolism. Chylomicrons secreted from the intestinal enterocyte also contain ApoA1 but it is quickly transferred to HDL in the bloodstream. The protein promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterol acyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. ApoA-I was also isolated as a prostacyclin (PGI2) stabilizing factor, and thus may have an anticlotting effect. Defects in the gene encoding it are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. In addition, it has been shown that ApoA1 is implicated in the anti-endotoxin function of HDL via interaction with lipopolysaccharide or endotoxin.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close